In this talk Vincent describes the journey in the development of Nostics and the background of the use of Machine Learning and Artificial Intelligence in its platform.

Sensitivity and specificity is extremely important in all types of diagnostics products. By using ML/AI algorithms, Nostics is able to gain high sensitivity and specificity for the detection of various pathogens. The main focus is on bacteria from culture, where the use of ML/AI allows us to accurately predict the outcomes of a sample measurement. The software infrastructure and classification models are key to achieve Nostics’ goal to enable accessible and affordable diagnostics.

Nostics:

• Vincent Laban, Co-founder & CEO Nostics.

Panel Discussion: 17:00 – 17:15 CET